Loading organizations...
Loading organizations...
Clinical-stage biotech focused on precision therapies for kidney disease.
Goldfinch Biopharma has raised $155.0M across 2 funding rounds.
Goldfinch Biopharma has raised $155.0M in total across 2 funding rounds.
Goldfinch Biopharma has raised $155.0M in total across 2 funding rounds.
Goldfinch Biopharma's investors include Joy Ghosh, Ally Bridge Group, BlackRock, Casdin Capital, Gilead Sciences, Irving Investors, Schroders Capital, Wellington Management, Yonjin Capital, Abbie Celniker.
Goldfinch Biopharma has raised $155.0M across 2 funding rounds. Most recently, it raised $100.0M Series B in June 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 30, 2020 | $100.0M Series B | Joy Ghosh | Ally Bridge Group, BlackRock, Casdin Capital, Gilead Sciences, Irving Investors, Schroders Capital, Wellington Management, Yonjin Capital |
| Dec 14, 2016 | $55.0M Series A | Abbie Celniker |